[144] Natera, Inc. SEC Filing
Rhea-AI Filing Summary
Natera, Inc. (NTRA) notice reports a proposed sale of 10,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,800,000. The filing lists 137,248,106 shares outstanding, so the block represents about 0.0073% of outstanding stock, indicating a very small ownership fraction being sold. The shares were acquired as a gift on 03/02/2020 from the issuer, and the filing discloses two recent sales in the past three months: 5,000 shares sold on 09/12/2025 for $852,707 and 1,718 shares sold on 07/28/2025 for $240,190.65. The filer certifies they are not aware of any undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Proposed sale is immaterial to market capitalization but shows continued insider/affiliate dispositions.
The notice documents a planned disposition of 10,000 common shares valued at $1.8 million via a major broker, representing approximately 0.0073% of issued shares. Recent dispositions of 5,000 and 1,718 shares in the prior three months indicate the filer or related parties have been selling modest tranches rather than liquidating a large position. For investors, these transactions are routine Rule 144 disclosures required when affiliates/insiders sell restricted or control securities; they do not by themselves indicate company performance changes.
TL;DR: Filing appears procedurally complete with broker and acquisition details; includes required representations.
The form includes broker identification, the nature of acquisition (gift from issuer), number of shares outstanding, and recent sales history, plus the filer’s representation of no undisclosed material adverse information. These elements satisfy typical Rule 144 disclosure requirements. Compliance risk appears low based on the disclosed information, though monitoring continued periodic sales is prudent for tracking insider liquidity patterns.